Journal article
Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
Abstract
BACKGROUND: The large number of patients worldwide infected with the SARS-CoV-2 virus has overwhelmed health-care systems globally. The Anti-Coronavirus Therapies (ACT) outpatient trial aimed to evaluate anti-inflammatory therapy with colchicine and antithrombotic therapy with aspirin for prevention of disease progression in community patients with COVID-19.
METHODS: The ACT outpatient, open-label, 2 × 2 factorial, randomised, controlled trial, …
Authors
Eikelboom JW; Jolly SS; Belley-Cote EP; Whitlock RP; Rangarajan S; Xu L; Heenan L; Bangdiwala SI; Tarhuni WM; Hassany M
Journal
The Lancet Respiratory Medicine, Vol. 10, No. 12, pp. 1160–1168
Publisher
Elsevier
Publication Date
December 2022
DOI
10.1016/s2213-2600(22)00299-5
ISSN
2213-2600